首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Construction and identification of small hairpin RNA plasmids targeting neuropilin-1 gene and their inhibitory effect on human nasopharyngeal carcinoma CNE-2Z cell proliferation in vitro and in vivo
【24h】

Construction and identification of small hairpin RNA plasmids targeting neuropilin-1 gene and their inhibitory effect on human nasopharyngeal carcinoma CNE-2Z cell proliferation in vitro and in vivo

机译:靶向neuropilin-1基因的小发夹RNA质粒的构建,鉴定及其对人鼻咽癌CNE-2Z细胞体外和体内增殖的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

We observed the effects of small hairpin RNA (shRNA) plasmids targeting neuropilin-1 (NRP-1) gene on human nasopharyngeal carcinoma (NPC) CNE-2Z cell growth in vitro and in vivo. Three fluorescein-labeled shRNA eukaryotic expression vectors targeting NRP-1 gene, including pSilencer-shRNA1, pSilencer-shRNA2 and pSilencer-shRNA3 were constructed. The three plasmids were, respectively, transfected into human NPC CNE-2Z cells. The most effective plasmid was injected into xenograft tumors in nude mice. The sequencing for these recombinant plasmids was consistent with that of designed shRNA templates. Green fluorescence was seen in the transfected CNE-2Z cells and xenograft tumors in nude mice. MTT assay indicated that CNE-2Z cell proliferation was significantly inhibited. PT-PCR and Western blot displayed that both mRNA and protein of NRP-1 gene were all decreased, particularly in the cells treated with shRNA3. At the end of the experiment, xenograft tumors in plasmid group (0.599 +/- 0.002 cm(3)) were significantly inhibited with a tumor inhibition rate of 48.6 %, as compared to those in negative (1.141 +/- 0.013 cm(3)) and blank control groups (1.165 +/- 0.308 cm(3)) (all P < 0.05). shRNA targeting NRP-1 gene can effectively inhibit human NPC CNE-2Z cell proliferation in vitro and in vivo. This provides an experiment basis for NPC gene therapy.
机译:我们观察到针对神经鼻蛋白-1(NRP-1)基因的小发夹RNA(shRNA)质粒在体外和体内对人鼻咽癌(NPC)CNE-2Z细胞生长的影响。构建了三个靶向NRP-1基因的荧光素标记的shRNA真核表达载体,包括pSilencer-shRNA1,pSilencer-shRNA2和pSilencer-shRNA3。将这三个质粒分别转染到人NPC CNE-2Z细胞中。将最有效的质粒注射到裸鼠的异种移植肿瘤中。这些重组质粒的测序与设计的shRNA模板一致。在裸鼠的转染的CNE-2Z细胞和异种移植肿瘤中观察到绿色荧光。 MTT测定表明CNE-2Z细胞增殖被显着抑制。 PT-PCR和Western blot显示,NRP-1基因的mRNA和蛋白均下降,特别是在shRNA3处理的细胞中。在实验结束时,与阴性组(1.141 +/- 0.013 cm(3)相比,质粒组(0.599 +/- 0.002 cm(3))的异种移植肿瘤被显着抑制,肿瘤抑制率为48.6%。 )和空白对照组(1.165 +/- 0.308 cm(3))(所有P <0.05)。靶向NRP-1基因的shRNA可在体内外有效抑制人NPC CNE-2Z细胞增殖。这为NPC基因治疗提供了实验依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号